```json
{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Expression of LRRK2 mutant genes, such as Y1699C, result in a loss of basal cell viability in SH-SY5Y cells demonstrating their innate toxicity.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a loss of cell viability due to the expression of the Y1699C mutant, indicating a toxic gain of function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses cell viability assays and ERK pathway activation assays to model LRRK2's role in oxidative stress response.",
          "judgment": "Yes",
          "reasoning": "Cell viability and ERK pathway activation assays are appropriate for modeling the disease mechanism of LRRK2-related Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The transfection efficiency was estimated by eye under fluorescence illumination to visualize GFP and compared to the total number of cells under bright field illumination for HEK293 cells typically showing at least 70% transfection efficiency.",
          "judgment": "Yes",
          "reasoning": "The study includes controls for transfection efficiency and uses replicates in experiments.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Cells expressing wild-type LRRK2 experienced 50% attenuation in H2O2-induced cell death relative to those cells expressing Y1699C or G2019S mutants.",
          "judgment": "No",
          "reasoning": "The study does not mention the use of known pathogenic or benign variant controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The Y1699C variant shows a loss of protective function against oxidative stress, supporting its pathogenic role, but lacks variant controls for stronger evidence."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "G2019S mutants show higher kinase activities than wild-type LRRK2, speculated to be involved in the manifestation of parkinsonian symptoms.",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism as increased kinase activity leading to parkinsonian symptoms."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses kinase activity assays and cell viability assays to model LRRK2's role in oxidative stress response.",
          "judgment": "Yes",
          "reasoning": "Kinase activity and cell viability assays are appropriate for modeling the disease mechanism of LRRK2-related Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The transfection efficiency was estimated by eye under fluorescence illumination to visualize GFP and compared to the total number of cells under bright field illumination for HEK293 cells typically showing at least 70% transfection efficiency.",
          "judgment": "Yes",
          "reasoning": "The study includes controls for transfection efficiency and uses replicates in experiments.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Cells expressing wild-type LRRK2 experienced 50% attenuation in H2O2-induced cell death relative to those cells expressing Y1699C or G2019S mutants.",
          "judgment": "No",
          "reasoning": "The study does not mention the use of known pathogenic or benign variant controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G2019S variant shows increased kinase activity and a loss of protective function against oxidative stress, supporting its pathogenic role, but lacks variant controls for stronger evidence."
    }
  ]
}
```